# US 2006/0068405 A1 · Methods and systems for annotating biomolecular sequences

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0068405 A1
- Document ID: US20060068405A1
- Status: Published application
- Kind: A1
- Application number: 11/043,860
- Filed: 2005-01-27
- Published: 2006-03-30
- Earliest claimed: 2004-01-27
- Inventors: Alex Diber; Sarah Pollock; Zurit Levine; Sergey Nemzer; Vladimir Grebinskiy; Brian Meloon; Andrew Olson; Avi Rosenberg; Ami Haviv; Shaul Zevin; Tomer Zekharia; Zipi Shaked; Moshe Olshansky; Ariel Farkash; Eyal Privman; Amit Novik; Naomi Keren; Gad Cojocaru; Pinchas Akiva; Yossi Cohen; Ronen Shemesh; Osnat Sella-Tavor; Liat Mintz; Hanqing Xie; Dvir Dahary; Erez Levanon; Shiri Freilich; Nili Beck; Wei-Yong Zhu; Alon Wasserman; Chen Chermesh; Idit Azar; Rotem Sorek; Jeanne Bernstein
- Web page: https://patentgrep.com/patent/US20060068405A1

## CPC

- C07K 14/705: Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)}
- A61P 35/00: Antineoplastic agents
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- G16B 30/10: Sequence alignment; Homology search
- G16B 30/20: Sequence assembly
- G16B 50/00: ICT programming tools or database systems specially adapted for bioinformatics
- G16B 50/10: Ontologies; Annotations
- G16B 25/20: Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Polypeptide sequences and polynucleotide sequences are provided. Also provided are annotative information concerning such sequences and uses for these sequences.

## Claims

### Claim 1

A computer readable storage medium, comprising a database stored in a retrievable manner, said database including biomolecular sequence information as set forth in files “Transcripts.gz”, and/or “Proteins.gz” of enclosed CD-ROM4, and biomolecular sequence annotations, as set forth in file “Annotations.gz” of enclosed CD-ROM4.

### Claim 2 (depends on 1)

The computer readable storage medium of claim 1, wherein said database further includes information pertaining to generation of said data and potential uses of said data.

### Claim 3 (depends on 1)

The computer readable storage medium of claim 1, wherein the medium is selected from the group consisting of a magnetic storage medium, an optical storage medium and an optico-magnetic storage medium.

### Claim 4

A method of comparing an expression level of a gene of interest in at least two types of tissues, the method comprising:
(a) obtaining a contig representing the gene of interest, said contig being assembled from a plurality of expressed sequences; and
(b) comparing a number of said plurality of expressed sequences corresponding to said contig which are expressed in each of the at least two tissue types, to thereby compare the expression level of the gene of interest in the at least two tissue types.

### Claim 5 (depends on 4)

The method of claim 4, wherein said plurality of expressed sequences present complete exonal coverage of the gene of interest.

### Claim 6 (depends on 4)

The method of claim 4, wherein said plurality of expressed sequences present partial exonal coverage of the gene of interest.

### Claim 7 (depends on 4)

The method of claim 4, wherein said obtaining said contig is effected by a sequence assembly software.

### Claim 8 (depends on 4)

The method of claim 4, further comprising scoring each of said plurality of said expressed sequences prior to (b), wherein said scoring is effected according to:
(i) expression level of each of said plurality of said expressed sequences; and
(ii) a quality of each of said plurality of said expressed sequences.

### Claim 9 (depends on 4)

The method of claim 4, wherein comparing is effected using statistical pairing analysis.

### Claim 10 (depends on 9)

The method of claim 9, wherein said statistical pairing analysis is Fisher exact test.

### Claim 11 (depends on 4)

The method of claim 4, wherein the at least two types of tissues are selected from the group consisting of tissues of different pathological origin, tissues of different developmental origin and tissues of a different cellular composition.

### Claim 12 (depends on 4)

The method of claim 4, further comprises computationally aligning sequences expressed in each of the at least two types of tissue with said contig to thereby identify said expressed sequences corresponding to said contig prior to (b).

### Claim 13

A method of comparing an expression level of at least two splice variants of a gene of interest in a tissue, the method comprising:
(a) obtaining a contig having exonal sequences of the at least two splice variants of the gene of interest, said contig being assembled from a plurality of expressed sequences;
(b) identifying at least one contig sequence region unique to one of the at least two splice variants of the gene of interest; and
(c) comparing a number of said plurality of expressed sequences in the tissue having said at least one contig sequence region with a number of said plurality of expressed sequences not-having said at least one contig sequence region, to thereby compare the expression level of the at least two splice variants of the gene of interest in the tissue.

### Claim 14 (depends on 13)

The method of claim 13, wherein said plurality of expressed sequences present complete exonal coverage of the gene of interest.

### Claim 15 (depends on 13)

The method of claim 13, wherein said plurality of expressed sequences present partial exonal coverage of the gene of interest.

### Claim 16 (depends on 13)

The method of claim 13, wherein said obtaining said contig is effected by a sequence assembly software.

### Claim 17 (depends on 13)

The method of claim 13, further comprising scoring each of said plurality of said expressed sequences prior to (c), wherein said scoring is effected according to:
(i) expression level of each of said plurality of said expressed sequences; and
(ii) a quality of each of said plurality of said expressed sequences.

### Claim 18 (depends on 13)

The method of claim 13, wherein comparing is effected using statistical pairing analysis.

### Claim 19 (depends on 18)

The method of claim 18, wherein said statistical pairing analysis is Fisher exact test.

### Claim 20 (depends on 13)

The method of claim 13, wherein the tissue is selected from the group consisting of a tissue of a pathological origin of interest, a tissue of a cellular composition of interest.

### Claim 21 (depends on 13)

The method of claim 13, further comprising comparing the number of said plurality of expressed sequences in the tissue having said at least one contig sequence region with a number of said plurality of expressed sequences of the contig.

### Claim 22

A computer readable storage medium comprising data stored in a retrievable manner, said data including sequence information of differentially expressed mRNA sequences as set forth in files “Transcripts.gz”, and/or “Proteins.gz” of enclosed CD-ROM4, and sequence annotations as set forth in annotation categories “#TS”, “#TAA” and/or “#TAAT”, in the file “Annotations.gz” of enclosed CD-ROM4.

### Claim 23 (depends on 22)

The computer readable storage medium of claim 22, wherein said database further includes information pertaining to generation of said data and potential uses of said data.

### Claim 24 (depends on 22)

The computer readable storage medium of claim 22, wherein said medium is selected from the group consisting of a magnetic storage medium, an optical storage medium and an optico-magnetic storage medium.

### Claim 25 (depends on 22)

The computer readable storage medium of claim 22, wherein said database further includes information pertaining to gain and/or loss of function of said differentially expressed mRNA splice-variants or polypeptides encoded thereby.

### Claim 26

A kit useful for detecting differentially expressed polynucleotide sequences, the kit comprising at least one oligonucleotide being designed and configured to be specifically hybridizable with a polynucleotide sequence selected from the group consisting of sequence files “Transcripts.gz” of enclosed CD-ROM4 under moderate to stringent hybridization conditions.

### Claim 27 (depends on 26)

The kit of claim 26, wherein said at least one oligonucleotide is labeled.

### Claim 28 (depends on 26)

The kit of claim 26, wherein said at least one oligonucleotide is attached to a solid substrate.

### Claim 29 (depends on 28)

The kit of claim 28, wherein said solid substrate is configured as a microarray and whereas said at least one oligonucleotide includes a plurality, of oligonucleotides each being capable of hybridizing with a specific polynucleotide sequence of the polynucleotide sequences set forth in the files “Transcripts.gz” of enclosed CD-ROM4 under moderate to stringent hybridization conditions.

### Claim 30 (depends on 29)

The kit of claim 29, wherein each of said plurality of oligonucleotides is being attached to said microarray in a regio-specific manner.

### Claim 31 (depends on 26)

The kit of claim 26, wherein said at least one oligonucleotide is designed and configured for DNA-hybridization.

### Claim 32 (depends on 26)

The kit of claim 26, wherein said at least one oligonucleotide is designed and configured for RNA hybridization.

### Claim 33

A system for generating a database of differentially expressed genes, the system comprising a processing unit, said processing unit executing a software application configured for:
(a) obtaining contigs representing genes of interest, each of said contigs being assembled from a plurality of expressed sequences;
(b) comparing a number of said plurality of expressed sequences corresponding to each of said contigs which are expressed in each of at least two tissue types, to thereby compare the expression level of the genes of interest in said at least two tissue types; and
(c) storing contigs which are supported by different numbers of said plurality of expressed sequences in each of said at least two tissue types, to thereby generate the database of differentially expressed genes.

### Claim 34

An isolated polynucleotide comprising a nucleic acid sequence being at least 80% identical to a nucleic acid sequence of the sequences set forth in file “Transcripts.gz” of the enclosed CD-ROM4.

### Claim 35 (depends on 34)

The isolated polynucleotide of claim 34, wherein said nucleic acid sequence is set forth in the file “Transcripts.gz” of the enclosed CD-ROM4.

### Claim 36

An isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide having an amino acid sequence at least 80% homologous to a sequence set forth in the file “Proteins.gz” of the enclosed CD-ROM4.

### Claim 37

An isolated polynucleotide comprising a nucleic acid sequence at least 80% identical to a sequence set forth in the file “Transcripts.gz” of the enclosed CD-ROM4.

### Claim 38

An isolated polypeptide having an amino acid sequence at least 80% homologous to a sequence set forth in the file “Proteins.gz” of the enclosed CD-ROM4.

### Claim 39

Use of a polynucleotide or polypeptide set forth in the file “Transcripts.gz” or “Proteins.gz” of the enclosed CD-ROM4 for the diagnosis and/or treatment of the diseases listed in herein.
